John Gilmore, MD
Otolaryngology/Facial Plastic Surgery · Dallas, TXNPI 1194778928
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,915 of the $3,622 with a category attached, or 80.5%. 17 manufacturers reported payments, led by Stryker at 41.1% of the total.
Across 84 payments — averaging $43.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Medtronic$1K
- Boehringer Ingelheim$255
- NEW World Medical,inc.$105
- Aerin Medical Inc.$99
- GSK$84
- plus $416 from 11 others
What the payments were for
- Travel & lodging$70720%
- Food & beverage$2,91580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 24 | $1,487 |
| Medtronic | 18 | $1,176 |
| Boehringer Ingelheim | 15 | $255 |
| NEW World Medical,inc. | 1 | $105 |
| Aerin Medical Inc. | 2 | $99 |
| GSK | 5 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Abbott | 4 | $67 |
| Alk-abello, Inc | 1 | $62 |
| Adlon Therapeutics L.p. | 3 | $55 |
| Integra Lifesciences Corporation | 1 | $34 |
| Optinose US, Inc. | 2 | $34 |
| Sanofi | 1 | $25 |
| Neurent Medical Limited | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $18 |
| Intersect ENT, Inc. | 1 | $15 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,622 in reported general payments places this provider in the 65th percentile of 51 otolaryngology/facial plastic surgery providers in Texas.
See all otolaryngology/facial plastic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $73,706 |
| Cefixime | 14 | $9,040 |
| Ipratropium Bromide | 88 | $2,285 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $1,687 |
| Montelukast Sodium | 169 | $1,204 |
| Fluticasone Propionate | 83 | $831 |
| Meclizine Hcl | 58 | $653 |
| Ofloxacin | 13 | $228 |
| Azithromycin | 19 | $75 |
| Amoxicillin | 28 | $63 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Dallas
- Christopher BrittDallas$5K
- Gunnar WestDallas$1K
- Dylan LippertDallas$598
- John StandeferDallas$506
- Lance OxfordDallas$312
- Michael KronenbergerDallas$218
- Jim GilmoreDallas$83
- Yula IndeyevaAustin$579K
- Manuel LopezSan Antonio$55K
- Michel SiegelHouston$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.